J Parathyr Dis. 2023;11: e11194.
doi: 10.34172/jpd.2023.11194
  Abstract View: 641
  PDF Download: 545

Clinical Trial

Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients

Negar Karevan 1 ORCID logo, Saeed Mardani 2* ORCID logo, Sara Karevan 3 ORCID logo, Hossein Mardanparvar 4 ORCID logo, Maryam Ghasemi 5 ORCID logo, Mohammad S Ghaffari 6

1 Department of Internal Medicine, Isfahan University of Medical Science, Isfahan, Iran.
2 Department of Nephrology, Shahrekord University of Medical Science, Shahrekord, Iran.
3 Department of Clinical Pharmacy, Student Research Committee, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Science, Sari, Iran.
4 Department of Nursing, Faculty of Nursing & Midwifery, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
5 Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA.
6 Department of Laboratory Science, Shahrekord University of Medical Science, Shahrekord, Iran.
*Corresponding Author: Corresponding author: Saeed Mardani, Email: mardani_S@skums.ac.ir, , Email: Dr.s.mardani72@gmail.com


Introduction: The role of vitamin D in metabolism, bone-mineral regulation, and anti-oxidation effect has drawn researchers’ attention toward its exact role in hemodialysis.

Objectives: In this study, the effect of uric acid level reduction on serum 25-hydroxy vitamin D levels in hemodialysis patients was assessed.

Patients and Methods: This study is a triple-blind clinical trial conducted on 81 hemodialysis patients suffering from asymptomatic hyperuricemia. Serum uric acid levels were assessed at the start of the study. Then patients were divided randomly into two groups of intervention and control. The intervention group received 100 mg of allopurinol tablets daily for two months. The control group received placebo tablets for the same duration. At the end of the study, 25-hydroxyvitamin D and uric acid levels were assessed. Data were analyzed using SPSS software and chi-square, independent t test, Mann–Whitney U, and Spearman’s rank correlation tests.

Results: In our study, two groups of control and intervention were similar in terms of patients’ demographic and hemodialysis characteristics. After the intervention, compared to the control group, the serum uric acid levels were significantly lower in the intervention group, while the level of 25-hydroxyvitamin D showed no significant difference between the two groups.

Conclusion: In this study, no significant effect of uric acid lowering therapy with vitamin D elevation in hemodialysis patients was detected.

Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (identifier: IRCT2015041721803N1; https:// en.irct.ir/trial/18996, ethical code#IR.SKUMS.1395.231).

Please cite this paper as: Karevan N, Mardani S, Karevan S, Mardanparvar H, Ghasemi M, Ghaffari MS. Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients. J Parathyr Dis. 2023;11:e11194. doi:10.34172/jpd.2023.11194.
First Name
Last Name
Email Address
Security code

Abstract View: 642

Your browser does not support the canvas element.

PDF Download: 545

Your browser does not support the canvas element.

Submitted: 13 Dec 2022
Accepted: 08 Jan 2023
ePublished: 09 Jan 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)